About Abelacimab Abelacimab is a novel, investigational, highly selective, fully human monoclonal antibody that binds tightly to Factor XI to block its activation and prevent the generation of the ...

Novartis To Beef Up Heart Disease Offering With $3 Billion Blackstone-Backed Anthos Therapeutics Deal Novartis is acquiring Anthos Therapeutics for up to $3.08 billion, adding abelacimab, a late ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

with the lead indication for prevention of stroke and systemic embolism in patients with atrial fibrillationAcquisition adds a late-stage asset and is aligned with Novartis strategic focus ...

A federal appeals court in the US has declined to overturn an attempt by Novartis to block the launch of a generic version of its blockbuster heart failure drug Entresto. The US Court of Appeals ...

The gospel of John is dramatically different than the synoptic gospels (Matthew, Mark and Luke). Instead of organizing historical events into a chronology, John presents Jesus in all of his ...

Novartis: 1996 – 2013 Dr Daniel Vasella was the first CEO of the newly merged company. Vasella was hired by Sandoz back in 1988 and remained there until 1992 when he was promoted to CEO of its ...

John Travolta, just like Olivia Newton-John, skyrocketed to fame following the release of the film musical Grease in 1978, the year after he danced his way across the big screen in Saturday Night ...

These nine Triad hotels rank among the state's best © 2025 American City Business Journals. All rights reserved. Use of and/or registration on any portion of this ...

John Werner has created a career out of bringing ideas, networks and people together to generate powerful results. John is a Managing Director and Partner at Link Ventures. John’s deep curiosity ...